BioMarin and Prosensa announce expiration of Hart-Scott-Rodino Waiting Period
BioMarin Pharmaceutical and Prosensa Holding announced the expiration of the mandatory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act on Dec. 23, 2014, with respect to BioMarin's pending acquisition of Prosensa. December 24, 2014